首页> 外文期刊>International Journal of Learning and Change >Purposing division strategy for pharmaceutical producer Dexa Medica in the demanding market
【24h】

Purposing division strategy for pharmaceutical producer Dexa Medica in the demanding market

机译:在苛刻的市场中为制药商Dexa Medica制定部门战略

获取原文
获取原文并翻译 | 示例
       

摘要

This research aims to purpose the division strategy for a pharmaceutical producer in Kalimantan area, named Dexa Medica Samarinda. Currently, this firm is facing a competitive market condition and evolving a decline position in the market. This research uses qualitative research method by organising intensive interview to important informants so that this research provides valid confirmations. Analyses of external factors are originated from macro and industry environment analysis. Internal factors are conducted from functional aspects in the organisation, then encounter them in the strengths, weaknesses, opportunities, and threats (SWOT) matrix. The proper business strategy formulation in order to face the competition is based on a matrix of external factor evaluation (EFE) and internal factor evaluation (IFE) that on Cell 1, which the Dexa Medica Samarinda as the company grow and build (growth and build). In this position, it is advisable to use a Dexa Medica concentration through vertical integration which is the main strategy improve the downstream quality and distribution system.
机译:这项研究的目的是针对加里曼丹地区一家名为Dexa Medica Samarinda的药品生产商制定部门战略。目前,该公司正面临竞争激烈​​的市场环境,并且市场地位不断下降。本研究采用定性研究方法,通过组织对重要信息提供者的深入访谈,从而为有效研究提供了依据。外部因素的分析源自宏观和行业环境分析。内部因素是从组织的职能方面进行的,然后在优势,劣势,机会和威胁(SWOT)矩阵中遇到它们。为了面对竞争,正确的业务策略制定基于外部因素评估(EFE)和内部因素评估(IFE)矩阵,该矩阵在Cell 1上随着公司的发展而壮大(发展与壮大) )。在此位置,建议通过垂直整合使用Dexa Medica浓缩液,这是改善下游质量和分销系统的主要策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号